Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255


Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer.

Sigel K, Lurslurchachai L, Bonomi M, Mhango G, Bergamo C, Kale M, Halm E, Wisnivesky J.

Lung Cancer. 2013 Nov;82(2):266-70. doi: 10.1016/j.lungcan.2013.06.011. Epub 2013 Sep 5.


Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.

Ezer N, Smith CB, Galsky MD, Mhango G, Gu F, Gomez J, Strauss GM, Wisnivesky J.

Radiother Oncol. 2014 Aug;112(2):272-8. doi: 10.1016/j.radonc.2014.07.014. Epub 2014 Aug 20.


Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer.

Wisnivesky JP, Bonomi M, Lurslurchachai L, Mhango G, Halm EA.

Eur Respir J. 2012 Oct;40(4):957-64. Epub 2012 Jan 12.


Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer.

Park CH, Bonomi M, Cesaretti J, Neugut AI, Wisnivesky JP.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):706-11. doi: 10.1016/j.ijrobp.2010.06.060. Epub 2010 Oct 6.


Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.

Wisnivesky JP, Halm E, Bonomi M, Powell C, Bagiella E.

Am J Respir Crit Care Med. 2010 Feb 1;181(3):264-9. doi: 10.1164/rccm.200907-1064OC. Epub 2009 Nov 5.


A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.

Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW Jr, Diehn M.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):872-84. doi: 10.1016/j.ijrobp.2013.12.010. Epub 2014 Feb 1.


Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.


Radiotherapy improves survival in unresected stage I-III bronchoalveolar carcinoma.

Urban D, Mishra M, Onn A, Dicker AP, Symon Z, Pfeffer MR, Lawrence YR.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):780-5. doi: 10.1016/j.ijrobp.2012.01.007. Epub 2012 Mar 13.


The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.

Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):340-7. doi: 10.1016/j.ijrobp.2011.05.070. Epub 2011 Nov 19.


Postoperative radiotherapy for elderly patients with stage III lung cancer.

Wisnivesky JP, Halm EA, Bonomi M, Smith C, Mhango G, Bagiella E.

Cancer. 2012 Sep 15;118(18):4478-85. doi: 10.1002/cncr.26585. Epub 2012 Feb 13.


Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer.

Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T.

Chest. 2005 Sep;128(3):1461-7.


Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.

Veluswamy RR, Mhango G, Bonomi M, Neugut AI, Hershman DL, Aldridge MD, Wisnivesky JP.

Ann Am Thorac Soc. 2013 Dec;10(6):622-8. doi: 10.1513/AnnalsATS.201305-127OC.


Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.

Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA, Smith BD.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1060-70. doi: 10.1016/j.ijrobp.2012.07.2354. Epub 2012 Sep 11.


Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation.

Chen AB, Neville BA, Sher DJ, Chen K, Schrag D.

J Clin Oncol. 2011 Jun 10;29(17):2305-11. doi: 10.1200/JCO.2010.33.4466. Epub 2011 May 2.


Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.


Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.

Malhotra J, Mhango G, Gomez JE, Smith C, Galsky MD, Strauss GM, Wisnivesky JP.

Ann Oncol. 2015 Apr;26(4):768-73. doi: 10.1093/annonc/mdv008. Epub 2015 Jan 18.


Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Shirvani SM, Jiang J, Gomez DR, Chang JY, Buchholz TA, Smith BD.

Lung Cancer. 2013 Nov;82(2):252-9. doi: 10.1016/j.lungcan.2013.08.015. Epub 2013 Aug 21.


Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.

Monirul Islam KM, Shostrom V, Kessinger A, Ganti AK.

Lung Cancer. 2013 Oct;82(1):90-4. doi: 10.1016/j.lungcan.2013.06.021. Epub 2013 Jul 31.


Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.

Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J Jr, Fossella F, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):616-25.

Items per page

Supplemental Content

Write to the Help Desk